Given that pancreatic cancer exhibits a unique GOT2-dependent glutamine metabolism, there must be other compensatory metabolic pathways for pancreatic cancer cells in vivo to survive under GOT2-deficient conditions. Here, GOT2 is linked to familial pancreatic carcinoma.